cilostazol has been researched along with Cerebral Amyloid Angiopathy in 2 studies
Cerebral Amyloid Angiopathy: A heterogeneous group of sporadic or familial disorders characterized by AMYLOID deposits in the walls of small and medium sized blood vessels of CEREBRAL CORTEX and MENINGES. Clinical features include multiple, small lobar CEREBRAL HEMORRHAGE; cerebral ischemia (BRAIN ISCHEMIA); and CEREBRAL INFARCTION. Cerebral amyloid angiopathy is unrelated to generalized AMYLOIDOSIS. Amyloidogenic peptides in this condition are nearly always the same ones found in ALZHEIMER DISEASE. (from Kumar: Robbins and Cotran: Pathologic Basis of Disease, 7th ed., 2005)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Tanaka, M | 1 |
Saito, S | 1 |
Inoue, T | 1 |
Satoh-Asahara, N | 1 |
Ihara, M | 2 |
Yakushiji, Y | 1 |
Kawamoto, K | 1 |
Uchihashi, K | 1 |
Aoki, S | 1 |
Nagaishi, Y | 1 |
Suzuyama, K | 1 |
Tsugitomi, Y | 1 |
Hara, H | 1 |
1 review available for cilostazol and Cerebral Amyloid Angiopathy
Article | Year |
---|---|
Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Ac | 2020 |
1 other study available for cilostazol and Cerebral Amyloid Angiopathy
Article | Year |
---|---|
Low-Dose Phosphodiesterase III Inhibitor Reduces the Vascular Amyloid Burden in Amyloid-β Protein Precursor Transgenic Mice.
Topics: Amyloid beta-Peptides; Animals; Blood Vessels; Brain; Cerebral Amyloid Angiopathy; Cilostazol; Femal | 2020 |